Cogstate Ltd

CGS

Company Profile

  • Business description

    Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.

  • Contact

    367 Collins Street
    Level 32
    MelbourneVIC3000
    AUS

    T: +61 396641300

    https://www.cogstate.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Health Information Services

    Fiscal Year End

    30 June 2026

    Employees

    249

Stocks News & Analysis

stocks

Will China strong arm BHP into lower iron ore prices?

Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.
stocks

Chart of the Week: Where Morningstar sees attractive dividend yields in 26/27

Charts from the Australian Dividend Outlook show the sectors where they are abundant.
stocks

2 picks in an undervalued ASX sector

Investors may be too pessimistic about this industry.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,244.8011.80-0.13%
CAC 408,060.1385.281.07%
DAX 4024,597.13211.350.87%
Dow JONES (US)46,601.781.20-0.00%
FTSE 1009,548.8765.290.69%
HKSE26,829.46128.31-0.48%
NASDAQ23,043.38255.021.12%
Nikkei 22547,734.99215.89-0.45%
NZX 50 Index13,610.1641.680.31%
S&P 5006,753.7239.130.58%
S&P/ASX 2008,947.6010.80-0.12%
SSE Composite Index3,882.7820.250.52%

Market Movers